Cargando…
Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography
INTRODUCTION: Double contrast-enhanced ultrasonography (DCUS) is a new method we used in predicting lymph node metastasis (LNM) in patients with early gastric cancer. MATERIAL AND METHODS: Seventy-six patients with early gastric cancer diagnosed by gastroscope and confirmed by pathology after operat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258739/ https://www.ncbi.nlm.nih.gov/pubmed/22295029 http://dx.doi.org/10.5114/aoms.2011.23412 |
_version_ | 1782221305181896704 |
---|---|
author | Xue, Nianyu Huang, Pintong Aronow, Wilbert S. Wang, Zongmin Nair, Chandra K. Zheng, Zhiqiang Shen, Xuedong Yin, Yimei Huang, Fuguang Cosgrove, David |
author_facet | Xue, Nianyu Huang, Pintong Aronow, Wilbert S. Wang, Zongmin Nair, Chandra K. Zheng, Zhiqiang Shen, Xuedong Yin, Yimei Huang, Fuguang Cosgrove, David |
author_sort | Xue, Nianyu |
collection | PubMed |
description | INTRODUCTION: Double contrast-enhanced ultrasonography (DCUS) is a new method we used in predicting lymph node metastasis (LNM) in patients with early gastric cancer. MATERIAL AND METHODS: Seventy-six patients with early gastric cancer diagnosed by gastroscope and confirmed by pathology after operation were examined using DCUS preoperatively. Group N1 included 15 patients with LNM and group N0 61 patients without LNM. RESULTS: In group N1, 13 patients (87%) had marked hyperenhancement during early arterial phase using DCUS, and 2 patients (13%) were unmarked as hyperenhancement. In group N0, 24 patients (39%) had marked hyperenhancement during early arterial phase using DCUS, and 37 patients (61%) had unmarked hyperenhancement. The sensitivity and specificity of marked hyperenhancement in predicting LNM in patients with early gastric cancer was 86.7% and 60.7% respectively, and the Youden’s index was 0.474. The κ value of this method was 0.89. CONCLUSIONS: Double contrast-enhanced ultrasonography is a new valuable method to evaluate LNM at an early stage of gastric cancer and prognosis of early gastric cancer preoperatively. |
format | Online Article Text |
id | pubmed-3258739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-32587392012-01-31 Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography Xue, Nianyu Huang, Pintong Aronow, Wilbert S. Wang, Zongmin Nair, Chandra K. Zheng, Zhiqiang Shen, Xuedong Yin, Yimei Huang, Fuguang Cosgrove, David Arch Med Sci Clinical Research INTRODUCTION: Double contrast-enhanced ultrasonography (DCUS) is a new method we used in predicting lymph node metastasis (LNM) in patients with early gastric cancer. MATERIAL AND METHODS: Seventy-six patients with early gastric cancer diagnosed by gastroscope and confirmed by pathology after operation were examined using DCUS preoperatively. Group N1 included 15 patients with LNM and group N0 61 patients without LNM. RESULTS: In group N1, 13 patients (87%) had marked hyperenhancement during early arterial phase using DCUS, and 2 patients (13%) were unmarked as hyperenhancement. In group N0, 24 patients (39%) had marked hyperenhancement during early arterial phase using DCUS, and 37 patients (61%) had unmarked hyperenhancement. The sensitivity and specificity of marked hyperenhancement in predicting LNM in patients with early gastric cancer was 86.7% and 60.7% respectively, and the Youden’s index was 0.474. The κ value of this method was 0.89. CONCLUSIONS: Double contrast-enhanced ultrasonography is a new valuable method to evaluate LNM at an early stage of gastric cancer and prognosis of early gastric cancer preoperatively. Termedia Publishing House 2011-06 2011-07-11 /pmc/articles/PMC3258739/ /pubmed/22295029 http://dx.doi.org/10.5114/aoms.2011.23412 Text en Copyright © 2011 Termedia & Banach http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Research Xue, Nianyu Huang, Pintong Aronow, Wilbert S. Wang, Zongmin Nair, Chandra K. Zheng, Zhiqiang Shen, Xuedong Yin, Yimei Huang, Fuguang Cosgrove, David Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography |
title | Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography |
title_full | Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography |
title_fullStr | Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography |
title_full_unstemmed | Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography |
title_short | Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography |
title_sort | predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258739/ https://www.ncbi.nlm.nih.gov/pubmed/22295029 http://dx.doi.org/10.5114/aoms.2011.23412 |
work_keys_str_mv | AT xuenianyu predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography AT huangpintong predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography AT aronowwilberts predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography AT wangzongmin predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography AT nairchandrak predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography AT zhengzhiqiang predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography AT shenxuedong predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography AT yinyimei predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography AT huangfuguang predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography AT cosgrovedavid predictinglymphnodestatusinpatientswithearlygastriccarcinomausingdoublecontrastenhancedultrasonography |